INTERNATIONAL PATENT: HANMI PHARM. CO., LTD., 한미약품 주식회사 FILES APPLICATION FOR "NOVEL HETEROBICYCLIC COMPOUND FOR INHIBITING YAP-TEAD INTERACTION AND PHARMACEUTICAL COMPOSITION COMPRISING SAME"

GENEVA, July 3 -- HANMI PHARM. CO., LTD. (214, Muha-ro, Paltan-myeon,Hwaseong-si,Gyeonggi-do 18536), 한미약품 주식회사 (경기도화성시팔탄면 무하로 214) filed a patent application (PCT/KR2024/020781) for "NOVEL HETEROBICYCLIC COMPOUND FOR INHIBITING YAP-TEAD INTERACTION AND PHARMACEUTICAL COMPOSITION COMPRISING SAME" on Dec 20, 2024. With publication no. WO/2025/135855, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

I...